Cargando…

Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis

BACKGROUND: TRIB3 is a human homologue of Drosophila tribbles. Previous studies have shown that TRIB3 controls the cell growth through ubiquitination-dependent degradation of other proteins, whereas its significance in the prognosis of colorectal cancer (CRC) is not yet fully understood. MATERIALS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyoshi, N, Ishii, H, Mimori, K, Takatsuno, Y, Kim, H, Hirose, H, Sekimoto, M, Doki, Y, Mori, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778541/ https://www.ncbi.nlm.nih.gov/pubmed/19904274 http://dx.doi.org/10.1038/sj.bjc.6605361

Ejemplares similares

ANXA9 gene expression in colorectal cancer: A novel marker for prognosis
por: MIYOSHI, NORIKATSU, et al.
Publicado: (2014)

Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
por: Ishikawa, K, et al.
Publicado: (2008)

MACC1 expression levels as a novel prognostic marker for colorectal cancer
por: YAMAMOTO, HIROFUMI, et al.
Publicado: (2014)

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
por: Takahashi, Y, et al.
Publicado: (2014)

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer
por: Takahashi, Y, et al.
Publicado: (2013)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma
por: Miyoshi, A, et al.
Publicado: (2005)

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
por: Glasgow, S C, et al.
Publicado: (2005)

High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients
por: Itakura, M, et al.
Publicado: (2013)

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
por: Kurokawa, Y, et al.
Publicado: (2014)

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer
por: Gaber, A, et al.
Publicado: (2009)

Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis
por: Qu, P, et al.
Publicado: (2008)

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
por: Gormley, J A, et al.
Publicado: (2011)

The beneficial effect of palliative resection in metastatic colorectal cancer
por: Park, J H, et al.
Publicado: (2013)

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007)

Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
por: Haug, U, et al.
Publicado: (2007)

P53 abnormalities and outcomes in colorectal cancer: a systematic review
por: Munro, A J, et al.
Publicado: (2005)

Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
por: Nakai, Y, et al.
Publicado: (2010)

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
por: Lu, C-Y, et al.
Publicado: (2013)

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer
por: Okugawa, Y, et al.
Publicado: (2010)

The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study
por: Tang, L-Q, et al.
Publicado: (2014)

A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation
por: Bruce, W R, et al.
Publicado: (2005)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Prognostic impact of histological categorisation of epithelial–mesenchymal transition in colorectal cancer
por: Ueno, H, et al.
Publicado: (2014)

A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
por: Ikeda, M, et al.
Publicado: (2007)

CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
por: Fukusumi, T, et al.
Publicado: (2014)

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer
por: Poikonen, P, et al.
Publicado: (2005)

HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients
por: Del Rio, Ana Paula Toledo, et al.
Publicado: (2013)

Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers
por: Takakura, M, et al.
Publicado: (2012)

Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis
por: Nosho, K, et al.
Publicado: (2005)

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
por: Shao, Y-Y, et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
por: Lim, S H, et al.
Publicado: (2015)

New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer
por: Gobbi, P G, et al.
Publicado: (2008)

Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
por: Yoshioka, T, et al.
Publicado: (2009)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Evidence for a role of TRIB3 in the regulation of megakaryocytopoiesis
por: Butcher, Lee, et al.
Publicado: (2017)

Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
por: Hur, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vuggnrpcgj3elmpiu3v9l228a6